Dr. Turner is the Head of Infection at the non-governmental organization which is based in the United Kingdom and which facilitates medical research.Continue...
“We are delighted that the Dangote Foundation is joining the Wellcome Trust and others in the international consortium of funders to develop a multi-pronged approach to combating Ebola.
“This is a fast-moving scene at present and it is not yet clear precisely which partners will fund which components of the work that we hope will lead to new diagnostics, drugs and vaccines.
“What is more important is that the partners are all not just talking about the problems, but actually trying to make things happen and the future inevitable epidemics. If things go well, we hope to know whether this candidate vaccine is safe, with some prospect of protecting people by Christmas.”
“The vaccine that is being tested in Oxford, and then in The Gambia and Mali, is being given to the consortium by NIH. It was originally developed by a company called Okairos, which was taken over by GSK last year.
“We are delighted that both NIH and GSK have been very open to sharing the vaccine and information about it with Oxford consortium, recognizing that by sharing we can collectively speed development,”
Turner also reportedly added that the trust is working with the National Institutes of Health and GlaxoSmithKline in the US and testing would soon begin in Oxford, England, as well as two other African countries.
